The Masonic Cancer Center creates a collaborative research environment focused on the causes, prevention, detection, and treatment of cancer; applying that knowledge to improve quality of life for patients and survivors; and sharing its discoveries with other scientists, students, professionals, and the community. Founded in 1991, the cancer center became a National Cancer Institute-designated comprehensive cancer center in 1997, one of only 41 institutions in the United States and two in Minnesota to hold that designation.
More than 500 faculty and staff are members of the Masonic Cancer Center. It is home to some of the world's top cancer researchers in bone marrow transplantation, breast cancer, bone cancer, cancer genetics, tobacco research, immunology, new therapies development, pediatric oncology, chemoprevention, and epidemiology.
- Research is organized into seven programs that focus on specific themes.
- The Cancer Information Line 1-888-CANCER MN (1-888-226-2376) is available for residents of Minnesota, Iowa, North Dakota, South Dakota, and Wisconsin.
- Through clinical trials, researchers learn which approaches are more effective than others.
- Program meetings, seminars, and other interdisciplinary meetings at the Masonic Cancer Center brings together experts from different fields to address the problem of cancer.
- Members can apply for internal grant mechanisms available through the Masonic Cancer Center Internal Grants Program which is offered on an annual basis. The overall goal of this program is to foster the development of and provide support for novel research ideas that focus on a problem in cancer. In turn, the Cancer Center expects that these internal awards will lead to nationally peer reviewed funding.
News and Events
Natalie Wolf, sarcoma survivor and U of M student, conducts sarcoma research in the Masonic Cancer Center
The November issue of Rein in Sarcoma newsletter featured Natalie Wolf, a University of Minnesota student and sarcoma survivor, who is working in the laboratory of David Largaespada, Ph.D., Genetic Mechanisms of Cancer Program.Read more.
Closing in on cancer
Earlier this year researcher Reuben Harris, Ph.D.,Genetic Mechanisms of Cancer Program member, and his colleagues found evidence that one of our own proteins is a major source of mutations in breast cancer. The researchers published evidence implicating the protein—an enzyme called APOBEC3B—in the international journal Nature. Read more.
Update is an official newsletter of the Masonic Cancer Center for faculty, members, staff, colleagues, and friends.